Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
Frontiers in Oncology · 04.01.2023 · 12
DOI: 10.3389/fonc.2022.1104810 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 04.01.2023. Verfasst von Ming-Yang Ge und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background & Aims Tumor-associated chronic inflammation has been determined to play a crucial role in tumor progression, angiogenesis and immunosuppression. The objective of this study was to assess the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in perihilar cholangiocarcinoma (pCCA) patients following curative resection.
Methods
Consecutive pCCA patients following curative resection at 3 Chinese hospitals between 2014 and 2018 were included. The NLR was defined as the ratio of neutrophil count to lymphocyte count. PLR was defined as the ratio of platelet count to lymphocyte count. The optimal cutoff values of preoperative NLR and PLR were determined according to receiver operating characteristic (ROC) curves for the prediction of 1-year overall survival (OS), and all patients were divided into high- and low-risk groups. Kaplan-Meier curves and Cox regression models were used to investigate the relationship between values of NLR and PLR and values of OS and recurrence-free survival (RFS) in pCCA patients. The usefulness of NLR and PLR in predicting OS and RFS was evaluated by time-dependent ROC curves.
Results
A total of 333 patients were included. According to the ROC curve for the prediction of 1-year OS, the optimal cutoff values of preoperative NLR and PLR were 1.68 and 113.1, respectively, and all patients were divided into high- and low-risk groups. The 5-year survival rates in the low-NLR (<1.68) and low-PLR groups (<113.1) were 30.1% and 29.4%, respectively, which were significantly higher than the rates of 14.9% and 3.3% in the high-NLR group (≥1.68) and high-PLR group (≥113.1), respectively. In multivariate analysis, high NLR and high PLR were independently associated with poor OS and RFS for pCCA patients. The time-dependent ROC curve revealed that both NLR and PLR were ideally useful in predicting OS and RFS for pCCA patients.
Conclusions
This study found that both NLR and PLR could be used to effectively predict long-term survival in patients with pCCA who underwent curative resection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- Department of Hepatobiliary Surgery, Sichuan Provincial People's Hospital, Chengdu, China.
- Department of Hepatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, China.
- Clinical Research Center of Oncology, Lishui Hospital of Zhejiang University, Lishui, China.
- Department of General Surgery, 903rd Hospital of People's Liberation Army, Hangzhou, China.
- Department of Health Statistics, College of Military Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ge, M. Y., Liu, Z. P., Pan, Y., Wang, J. Y., Wang, X., Dai, H. S., Gao, S. Y., Zhong, S. Y., Che, X. Y., Zuo, J. H., Liu, Y. H., Liu, X. C., Fan, H. N., Chen, W. Y., Wang, Z. R., Yin, X. Y., Bai, J., Zhang, Y. Q., Jiang, Y., …, & Chen, Z. Y. (2023). Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.1104810
Vancouver
Ge MY, Liu ZP, Pan Y, Wang JY, Wang X, Dai HS, et al. Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients. Frontiers in Oncology. 2023;12. doi:10.3389/fonc.2022.1104810
BibTeX
@article{Ge2023,
author = {Ge, Ming-Yang and Liu, Zhi-Peng and Pan, Yu and Wang, Jiao-Yang and Wang, Xiang and Dai, Hai-Su and Gao, Shu-Yang and Zhong, Shi-Yun and Che, Xiao-Yu and Zuo, Jing-Hua and Liu, Yun-Hua and Liu, Xing-Chao and Fan, Hai-Ning and Chen, Wei-Yue and Wang, Zi-Ran and Yin, Xian-Yu and Bai, Jie and Zhang, Yan-Qi and Jiang, Yan and Gong, Yi and Chen, Zhi-Yu},
title = {Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients},
journal = {Frontiers in Oncology},
year = {2023},
volume = {12},
doi = {10.3389/fonc.2022.1104810}
}
EUVIMED